Unveiling Tomorrow's Healthcare, Today

SK-Pharma Malta: Data-Driven, Global Impact

What We Do

Launch first generic on the market, make value added products accessible to the patients and caregivers based on the most novel treatment guidelines and best healthcare practices.

Our drug shortage department helps patients and hospitals across the world to receive required treatment in case of stock out issue alleviating the worldwide problem with supply.

Orphan drug supply, supporting patients with unmet needs in the rare disease segment by providing short-term named patient supply and full long-term access to vital rare disease drugs through government reimbursement programs.

what we do

Our Vision

abstract illustrative image of blues transparent pills

Our Vision

SK-Pharma Malta is a global pharmaceutical company committed to securing essential medications for patients in need globally. Our vision is to be the leading go-to company for embracing innovative new treatments by applying a patient-centric Approach, supported by a robust data science team. In today's ever-changing and advancing world, data is the key to success. We believe that the combination of data-driven organization with top-notch personnel is the key to leading in our endeavor to relieve patients with unmet medical needs.

our mission

Our Mission

SK-Pharma Malta's mission is to improve patients’ outcomes by enlarging healthcare professionals’ detection and diagnostic arsenal. Leveraging novel cutting-edge technologies allows SK to identify hidden opportunities and drive better healthcare to patients and caregivers.

Our focus is on the introduction of branded products and value-added medicines to the markets with the highest medical needs. The main target markets we operate in are MENA, Russia, CIS, and Balkans.

Our commitment goes way beyond the pill and applies a holistic approach that cutter data lakes that are processed by our own property algorithm and provide insights into potential novel treatment opportunities.

Our strength lies in harnessing expert theoretical knowledge into a machine learning-based model to enhance efficacy and performance by utilizing the latest technological advancement.

SK team is technologically oriental to cope with the company's ongoing mission and the ever-advancing innovative world that we are living in today.

abstract illustrative image related to pharmaceutical industry

Business Strategy:

Pioneering Success through Five Key Pillars

At our core, our company's strategy is built upon the foundation of five key pillars, each instrumental in charting our path to success:

Leading Business Development: We are committed to cultivating elite business development practices that enable us to effectively identify, nurture, and leverage growth opportunities.

Business Intelligence: Our ability to gather and analyze critical business intelligence empowers us to make informed decisions and stay ahead in the ever-evolving pharmaceutical landscape.

IP & Litigation Expertise: We possess a deep expertise in intellectual property and litigation matters, providing a competitive edge in protecting our innovations and assets.

Data Science: Harnessing the power of data science, we uncover valuable insights that drive strategic decision-making and enhance our product offerings.

Strategic Regulatory Affairs: Our strategic regulatory affairs efforts ensure compliance and facilitate a smooth journey for our products into the market.

Company's Strategic Direction:

These pillars collectively position us to lead in the domain of first-to-market and branded generic pharmaceuticals. We are dedicated to achieving this by forming strategic alliances, nurturing product development initiatives, and globally licensing specialty pharmaceutical products.

Our overarching objective is to ensure that 80% of our product launches are pioneers in their respective markets. Furthermore, we strive to secure a prominent presence in the branded generic sector, focusing on areas where treatment compliance and adherence can be notably enhanced.

In our pursuit of excellence, we draw inspiration from the 'Blue Ocean Strategy principles,' where opportunities lie in low competition and high growth areas. We maintain a laser focus on seizing early launch opportunities and addressing unmet needs, which serves as our primary catalyst for success within our stable business environment.

Embracing innovative technological advancements keeps us one step ahead of our competitors, facilitating rapid growth and operational efficiency. This forward-looking approach underscores our commitment to delivering superior solutions and making a lasting impact in the pharmaceutical industry.